0001209191-20-064433.txt : 20201218
0001209191-20-064433.hdr.sgml : 20201218
20201218163945
ACCESSION NUMBER: 0001209191-20-064433
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201216
FILED AS OF DATE: 20201218
DATE AS OF CHANGE: 20201218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Demski David M
CENTRAL INDEX KEY: 0001555392
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 201401092
MAIL ADDRESS:
STREET 1: C/O GLOBUS MEDICAL, INC.
STREET 2: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-16
0
0001237831
GLOBUS MEDICAL INC
GMED
0001555392
Demski David M
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
1
1
0
0
President, CEO
Class A Common Stock
2020-12-16
4
M
0
3125
43.77
A
151980
D
Class A Common Stock
2020-12-16
4
M
0
3125
43.58
A
155105
D
Class A Common Stock
2020-12-16
4
M
0
6250
29.31
A
161355
D
Class A Common Stock
2020-12-16
4
M
0
1666
26.27
A
163021
D
Class A Common Stock
2020-12-16
4
M
0
31137
25.52
A
194158
D
Class A Common Stock
2020-12-16
4
M
0
7053
24.10
A
201211
D
Class A Common Stock
2020-12-16
4
S
0
52356
64.20
D
148855
D
Class A Common Stock
2020-12-17
4
M
0
15864
24.10
A
164719
D
Class A Common Stock
2020-12-17
4
S
0
164719
64.20
D
0
D
Stock Option (Right to Buy Class A Common Stock)
43.77
2020-12-16
4
M
0
3125
0.00
D
2028-01-22
Class A Common Stock
3125
50000
D
Stock Option (Right to Buy Class A Common Stock)
43.58
2020-12-16
4
M
0
3125
0.00
D
2029-01-22
Class A Common Stock
3125
87500
D
Stock Option (Right to Buy Class A Common Stock)
29.31
2020-12-16
4
M
0
6250
0.00
D
2027-08-28
Class A Common Stock
6250
120000
D
Stock Option (Right to Buy Class A Common Stock)
26.27
2020-12-16
4
M
0
1666
0.00
D
2027-01-30
Class A Common Stock
1666
78334
D
Stock Option (Right to Buy Class A Common Stock)
25.52
2020-12-16
4
M
0
31137
0.00
D
2026-01-25
Class A Common Stock
31137
0
D
Stock Option (Right to Buy Class A Common Stock)
24.10
2020-12-16
4
M
0
7053
0.00
D
2025-01-20
Class A Common Stock
7053
15864
D
Stock Option (Right to Buy Class A Common Stock)
24.10
2020-12-17
4
M
0
15864
0.00
D
2025-01-20
Class A Common Stock
15864
0
D
This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.20 to $64.23, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on August 28, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on August 28, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
/s/ Kelly G. Huller, Attorney-in-Fact
2020-12-18